Absence of 4-1BB gene function exacerbates lacrimal gland inflammation in autoimmune-prone MRL-Faslpr mice

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 10, 2007, Pages 4608-4615

  Vinay, Dass S ^a   Kim, Jung D ^a,b   Asai, Tatsuhiko ^a,c   Choi, Beom K ^b   Kwon, Byoung S ^a,b  

^a LSU EYE CENTER   (United States)

^b University of Ulsan   (South Korea)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN 5; CYTOKINE; FODRIN; CD137 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CELL INFILTRATION; CELL LYSATE; EYE DISEASE; FLOW CYTOMETRY; GENE DELETION; GENE FUNCTION; IMMUNOMODULATION; LACRIMAL GLAND DISEASE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; T LYMPHOCYTE; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DACRYOCYSTITIS; ENZYME IMMUNOASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE SILENCING; GENETICS; IMMUNOBLOTTING; IMMUNOLOGY; LACRIMAL APPARATUS; MALE; METABOLISM; MOUSE MUTANT; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; NICK END LABELING; PATHOLOGY; PHYSIOLOGY; UPREGULATION;

ANIMALS; ANTIGENS, CD137; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DACRYOCYSTITIS; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE SILENCING; IMMUNOBLOTTING; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; INTERFERON TYPE II; INTERLEUKIN-4; LACRIMAL APPARATUS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED MRL LPR; MICE, KNOCKOUT; UP-REGULATION;

EID: 35748939397     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.07-0153     Document Type: Article

References (48)

1. van Blokland SCA, Versnel MA. Pathogenesis of Sjögren's syndrome: characteristics of different mouse models for autoimmune exocrinopathy. Clin Immunol. 2002;103:111-124.
2. Fox RI. Sjögren's syndrome. Curr Opin Rheumatol. 1995;7:409-416.
3. Talal N. Sjögren's syndrome. Curr Opin Immunol. 1989-1990;2:622-624.
4. Vinay DS, Kwon BS. Role of 4-1BB in immune responses. Semin Immunol. 1998;10:481-489.
5. Croft M. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity. Nat Rev Immunol. 2003;3:609-620.
6. Mittler RS, Foell J, McCausland M, et al. Anti-CD137 antibodies in the treatment of autoimmune disease and cancer. Immunol Res. 2004;29:197-208.
7. + immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity. 2002;16:311-323.
8. Wilcox RA, Chapoval AI, Gorski KS, et al. Expression of functional CD137 receptor by dendritic cells. J Immunol. 2002;168:4262-4267.
9. Takahashi C, Mittler RS, Vella AT. 4-1BB is a bona-fide CD8 T cell survival signal. J Immunol. 1999;162:5037-5040.
10. Hurtado JC, Kim YJ, Kwon BS. Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death. J Immunol. 1997;158:2600-2609.
11. Vinay DS, Cha K, Kwon BS. Dual immunoregulatory pathways of 4-1BB signaling. J Mol Med. 2006;84:726-736.
12. Kwon BS, Hurtado JC, Lee ZH, et al. Immune responses in 4-1BB (CD137)-deficient mice. J Immunol. 2002;168:5483-5490.
13. Vinay DS, Choi BK, Bae JS, Kim WY, Gebhardt BM, Kwon BS. CD137-deficient mice have reduced NK/NKT cell numbers and function, are resistant to lipopolysaccharide-induced shock syndromes, and have lower IL-4 responses. J Immunol. 2004;173:4218-4229.
14. Seo SK, Park YH, Choi JH, et al. Blocking 4-1BB/4-1BB ligand interactions prevents herpetic stromal keratitis. J Immunol. 2003;171:576-583.
15. Adamson TC, Fox RI, Frisman DM, Howell FV. Immunohistological analysis of lymphoid infiltrates in primary Sjögren's syndrome using monoclonal antibodies. J Immunol. 1983;130:203-208.
16. Jabs DA, Prenderghast RA. Reactive lymphocytes in lacrimal gland and renal vasculatic lesions of autoimmune MRL/lpr mice express L3T4. J Exp Med. 1987;166:1198-1203.
17. Ohno K, Takahashi T, Maki K, Ueda M, Taguchi O. Successful transfer of localized autoimmunity with positively selected CD4+ cell to SCID mice lacking functional B cell. Autoimmunity. 1999;29:103-110.
18. Tabbara K, Sharara N. Sjögren's syndrome: pathogenesis. Eur J Ophthalmol. 1999;9:1-7.
19. Lee SW, Vella AT, Kwon BS, Croft M. Enhanced CD4 T cell responsiveness in the absence of 4-1BB. J Immunol. 2005;174:6803-6808.
20. Maerten P, Kwon BS, Shen C, et al. Involvement of 4-1BB (CD137)-4-1BB ligand interaction in the modulation of CD4 T cell-mediated inflammatory colitis. Clin Exp Immunol. 2006;143:228-236.
21. Sakamoto R, Bennett ES, Henry VA, et al. The phenol red thread tear test: a cross-cultural study. Invest Ophthalmol Vis Sci. 1993;34:3510-3514.
22. Jabs DA, Lee B, Burek CL, Saboory AM, Prenderghast RA. Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL/Mp-lpr/lpr mice. Invest Ophthalmol Vis Sci. 1996;37:377-383.
23. Sjögren H. Zur Kenntnis Keratocunjuctivitis sicca. Acta Ophthalmol. 1933;2:1-151.
24. Theofilopoulos AN, Dixon FJ. Etiopathogenesis of murine SLE. Immunol Rev. 1981;55:179-216.
25. Theofilopoulos AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol. 1985;37:269-390.
26. Talal N, Moutsopoulos HM, Kassan SS. Sjögren's Syndrome: Clinical and Immunological Aspects. Berlin: Springer-Verlag; 1987;193-199.
27. Jabs DA, Prenderghast RA. Autoimmune ocular disease in MRL/Mp-lpr/lpr mice is suppressed by anti-CD4 antibody. Invest Ophthalmol Vis Sci. 1991;32:2718-2722.
28. Barabino S, Dana MR. Animal models of dry eye: a critical assessment of opportunities and limitations. Invest Ophthalmol Vis Sci. 2004;45:1641-1646.
29. Hirai S, Ishida N, Watanabe K, Mita S. Leakage of aquaporin 5 in the tear of dacryoadenitis mice. Invest Ophthalmol Vis Sci. 2000;41:2432-2437.
30. Haneji N, Nakamura T, Takio K, et al. Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome. Science. 1997;276:604-607.
31. Saegusa K, Ishimaru N, Yanagi K, et al. Prevention and induction of autoimmune exocrinopathy is dependent on pathogenic autoantigen cleavage in murine Sjogren's syndrome. J Immunol. 2002;169:1050-1057.
32. Vanags DM, Pörn-Ares MI, Coppola S, Burgess DH, Orrenius S. Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J Biol Chem. 1996;271:31075-31085.
33. Cohen PL, Eisenberg RA. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol. 1991;9:243-269.
34. Jabs DA, Prenderghast RA. Murine models of Sjögren's syndrome: immunohistological analysis of different strains. Invest Ophthalmol Vis Sci. 1988;29:1437-1443.
35. Skarstein K, Johannessen AC, Holmdahl R, Johnson R. Effects of sialadenitis after cellular transfer in autoimmune MRL/lpr mice. Clin Immunol Immunopathol. 1997;84:177-184.
36. Johnson R, Tarkowski A, Backman K, Holmdahl R, Klareskog L. Sialadenitis in the MRL-lpr mouse: morphological and immunohistochemical characterization of resident and infiltrating cells. Immunology. 1987;60:611-616.
37. Johnson R, Holmdahl R. Infiltrating mononuclear cells in salivary glands and kidneys in autoimmune MRL/Mp-lpr/lpr mice express IL-2 receptor and produce interferon-gamma. J Oral Pathol Med. 1990;19330-334.
38. Hayashi Y, Haneji N, Hamano H, Yanag, K. Transfer of Sjögren's syndrome-like autoimmune lesions into SCID mice and prevention of lesions by anti-CD4 and anti-T cell receptor antibody treatment. Eur J Immunol. 1994;24:2826-2831.
39. Jabs DA, Lee B, Whittum-Hudson J, Prendergast RA. The role of Fas-Fas ligand-mediated apoptosis in autoimmune lacrimal gland disease in MRL/MpJ mice. Invest Ophthalmol Vis Sci. 2001;42:399-401.
40. Ishida N, Hirai SI, Mita S. Immunolocalization of aquaporin homologs in mouse lacrimal glands. Biochem Biophys Res Commun. 1997;238:891-895.
41. Tsubota K, Hirai S, King LS, Agre P, Ishida N. Defective cellular trafficking of lacrimal gland aquaporin-5 in Sjögren's syndrome. Lancet. 2001;357:688-689.
42. Zoukhri D, Kublin CL. Impaired neurotransmitter release from lacrimal and salivary gland nerves of a murine model of Sjögren's syndrome. Invest Ophthalmol Vis Sci. 2001;42:925-932.
43. Murray LJ, Lee R, Martens C. In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp-lpr/lpr mouse. Eur J Immunol. 1990;20:163-170.
44. Takahashi S, Fossati L, Iwamoto M, et al. Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J Clin Invest. 1996;42:561-568.
45. Jabs DA, Prenderghast RA, Rorer EM, Hudson AP, Whittum-Hudson A. Cytokines in autoimmune lacrimal gland disease in MRL/MpJ mice. Invest Ophthalmol Vis Sci. 2001;42:2567-2571.
46. Jabs DA, Lee B, Whitum-Hudson JA, Prenderghast RA. Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice. Invest Ophthalmol Vis Sci. 2000;41:826-831.
47. Straus SE, Sneller M, Lenardo MJ, Puck JM, Strober W. An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome. Ann Intern Med. 1999;130:591-601.
48. Jabs DA, Burns WH, Prenderghast RA. Paradoxic effect of anti-CD4 therapy on lacrimal gland disease in MRL/Mp-lpr/lpr mice. Invest Ophthalmol Vis Sci. 1996;37:246-250.